Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Leukemia 31Leukemia, Promyelocytic, Acute 26Multiple Myeloma 17Leukemia, Myeloid, Acute 16Neoplasms, Plasma Cell 12Myelodysplastic Syndromes 12Leukemia, Myelomonocytic, Chronic 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Anemia, Refractory, with Excess of Blasts 7Lymphoma 6Leukemia, Monocytic, Acute 6Leukemia, Lymphocytic, Chronic, B-Cell 6Blast Crisis 6Neoplasms 5Lymphoma, Non-Hodgkin 5Lymphoma, Follicular 5Leukemia, Myelomonocytic, Acute 5Leukemia, Megakaryoblastic, Acute 5Leukemia, Erythroblastic, Acute 5Burkitt Lymphoma 5Recurrence 4Myeloproliferative Disorders 4Myelodysplastic-Myeloproliferative Diseases 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large B-Cell, Diffuse 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Central Nervous System Neoplasms 4

Interventions

pembrolizumab 287Nivolumab 258Ipilimumab 236Cyclophosphamide 135aldesleukin 134Interleukin-2 104Temozolomide 75Dacarbazine 74trametinib 70Vemurafenib 69fludarabine 68dabrafenib 65fludarabine phosphate 62sargramostim 44binimetinib 44Radiosurgery 44Biopsy 43Paclitaxel 42Bevacizumab 42incomplete Freund's adjuvant 39encorafenib 37Radiotherapy 36Cisplatin 36CTLA-4 Antigen 36atezolizumab 35Carboplatin 35Magnetic Resonance Spectroscopy 33cobimetinib 32Specimen Handling 31Introns 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Melanoma × Arsenic Trioxide × Clear all
NCT00571116 2019-08-07

Disulfiram Plus Arsenic Trioxide In Patients With Metastatic Melanoma and at Least One Prior Systemic Therapy

University of California, Irvine

Phase 1 Terminated
9 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡